LASER TREATMENT AND ANTI-PD-1 IMMUNOTHERAPY PROLONG SURVIVAL IN A MOUSE MODEL OF SQUAMOUS CELL CARCINOMAS

被引：0
|
作者：
Christensen, Rikke L.
Omland, Silje H.
Lerche, Catharina M.
Philipsen, Peter A.
Olesen, Uffe H.
Haedersdal, Merete
机构：
[1] Bispebjerg Hosp, Copenhagen, Denmark
[2] Copenhagen Univ Hosp, Dept Dermatol, Copenhagen, Denmark
[3] Copenhagen Univ Hosp, Wound Healing Ctr, Copenhagen, Denmark
来源：
LASERS IN SURGERY AND MEDICINE | 2022年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [31] COMBINING ANTI-PD-1 (B7-H1) IMMUNOTHERAPY WITH STEREOTACTIC RADIOSURGERY IN A MOUSE ORTHOTOPIC GLIOBLASTOMA MODEL
    Zeng, Jing
    See, Alfred P.
    Phallen, Jillian
    Belcaid, Zineb
    Durham, Nicholas
    Meyer, Christian
    Albesiano, Emilia
    Pradilla, Gustavo
    Ford, Eric
    Hammers, Hans
    Tyler, Betty
    Brem, Henry
    Tran, Phuoc T.
    Pardoll, Drew
    Drake, Charles G.
    Lim, Michael
    NEURO-ONCOLOGY, 2011, 13 : 37 - 38
  • [32] Anti-PD-1/PD-L1 immunotherapy in conversion treatment of locally advanced hepatocellular carcinoma
    Chen, Jiaqi
    Zhang, Ding
    Yuan, Ying
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (03) : 579 - 590
  • [33] Anti-PD-1/PD-L1 immunotherapy in conversion treatment of locally advanced hepatocellular carcinoma
    Jiaqi Chen
    Ding Zhang
    Ying Yuan
    Clinical and Experimental Medicine, 2023, 23 : 579 - 590
  • [34] Treatment-related lymphopenia impairs the treatment response of anti-PD-1 therapy in esophageal squamous cell carcinoma
    Yin, Tianwen
    Wang, Peiliang
    Yu, Jinming
    Teng, Feifei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 106
  • [35] Dynamic profiling of immune microenvironment during anti-PD-1 immunotherapy for head and neck squamous cell carcinoma: the IPRICE study
    Helene, Carinato
    Conrad, Ombline
    Pflumio, Carole
    Borel, Christian
    Voegelin, Manon
    Bernard, Alexandre
    Schultz, Philippe
    Onea, Mihaela-Alina
    Jung, Alain
    Martin, Sophie
    Burgy, Mickal
    BMC CANCER, 2023, 23 (01)
  • [36] Dynamic profiling of immune microenvironment during anti-PD-1 immunotherapy for head and neck squamous cell carcinoma: the IPRICE study
    Carinato Hélène
    Ombline Conrad
    Carole Pflumio
    Christian Borel
    Manon Voegelin
    Alexandre Bernard
    Philippe Schultz
    Mihaela-Alina Onea
    Alain Jung
    Sophie Martin
    Mickaël Burgy
    BMC Cancer, 23
  • [37] Knockout of immunotherapy prognostic marker genes eliminates the effect of the anti-PD-1 treatment
    Naixue Yang
    Fansen Ji
    Liqing Cheng
    Jingzhe Lu
    Xiaofeng Sun
    Xin Lin
    Xun Lan
    npj Precision Oncology, 5
  • [38] Knockout of immunotherapy prognostic marker genes eliminates the effect of the anti-PD-1 treatment
    Yang, Naixue
    Ji, Fansen
    Cheng, Liqing
    Lu, Jingzhe
    Sun, Xiaofeng
    Lin, Xin
    Lan, Xun
    NPJ PRECISION ONCOLOGY, 2021, 5 (01)
  • [39] CD40/anti-PD-1 sequential immunotherapy outperforms multiple immunotherapy combinations in an oral cancer prevention mouse model.
    Novaes, Jose A. Monteiro de Oliveira
    Poteete, Alissa
    Pisegna, Marlese
    William, William N.
    Heymach, John V.
    CANCER IMMUNOLOGY RESEARCH, 2021, 9 (02)
  • [40] High dimensional single cell analysis predicts response to anti-PD-1 immunotherapy
    Krieg, Carsten
    Nowicka, Malgorzata
    Guglietta, Silvia
    Schindler, Sabrina
    Hartmann, Felix J.
    Weber, Lukas M.
    Dummer, Reinhard
    Robinson, Mark D.
    Levesque, Mitchell P.
    Becher, Burkhard
    CANCER RESEARCH, 2018, 78 (13)
12345